Spread & Containment
NHS Consultant Says Staff Are Being Silenced Over COVID-19
NHS Consultant Says Staff Are Being Silenced Over COVID-19
Share this:
Although we cannot verify his or her identity, we still think our readers should see it:
1) because it dovetails with other verified reports, and
2) if it is what it alleges to be, it sheds concerning light on the state of things inside the healthcare system
First published on The Bernicean, the below statement is allegedly from a senior consultant working for the NHS in a hospital in Surrey, describing the criminal gagging of all levels of NHS staff, who have been threatened that they will lose their jobs if the speak out about the COVID-19 pandemic.
I am a consultant at a major, regional hospital in Surrey. By major you can take that to indicate that we have an A&E department. I had agreed to give an interview to an anti lockdown activist in which I would have revealed my identity. I have since changed my mind and only feel able to give an anonymous statement.
I have changed my mind simply because that all staff, no matter what grade, at all hospitals have been warned that if they give any media interviews at all or make any statements to either the Main Stream Press or smaller, independent press/social media we may, immediately be suspended without pay. I have a family, dependents and I simply cant do it to them.
I therefore can not reveal my identity at this time but wish to state as follows:
In my opinion, and that of many of my colleagues, there has been no Covid Pandemic, certainly not in the Surrey region and I have heard from other colleagues this picture is the same throughout the country. Our hospital would normally expect to see around 350,000 out patients a year. Around 95,000 patients are admitted to hospital in a normal year and we would expect to see around a similar figure, perhaps 100,000 patients pass through our A&E department.
In the months from March to June (inclusive) we would normally expect to see 100,000 out patients, around 30,000 patients admitted to hospital and perhaps 30,000 pass through A&E. This year (and these figures are almost impossible to get hold of) we are over 95% down on all those numbers. In effect, the hospital has been pretty much empty for that entire period.
At the start, staff that questioned this were told that we were being used as ‘redundant’ capacity, kept back for the ‘deluge’ we were told would come. It never did come, and when staff began to question this, comments like, ‘for the greater good’ and to ‘protect the NHS’ came down from above. Now its just along the lines of, ‘Shut up or you don’t get paid’.
The few Covid cases that we have had get repeatedly tested, and every single test counted as a new case. Meaning the figures reported back to ONS/PHE (Office for National Statistics & Public Health England) were almost exponentially inflated. It could be that Covid cases reported by hospitals are between 5 to 10x higher than the real number of cases. There has been no pandemic and this goes a long way to explain why figures for the UK are so much higher than anywhere else in Europe.
The trust has been running empty ambulances during lockdown and is still doing it now. By this I mean ambulances are driving around, with their emergency alert systems active (sirens &/or lights) with no job to go to. This I believe has been to give the impression to the public that there is more demand for ambulances than there actually is. Staff only wear face coverings/masks & social distance when public facing, as soon as they are out of public view, the masks come off and social distancing is not observed.
Indeed jokes are made about the measures, and I have heard staff express amazement that despite warnings on packets and at point of sales, telling people masks are totally ineffective and dangerous, the public still buy them, because a politician has told them too.
We have cancelled the vast majority of operations and of these ALL elective surgery has been cancelled. That’s surgery that has been pre planned / waiting list. Non-elective Surgery, this tends to be emergency surgery or that which is deemed urgent has been severely curtailed. The outcome of this is simple. People are at best being denied basic medical care and at worst, being left to die, in some cases, in much distress and pain.
Regarding death certification. All staff that are responsible for this have been encouraged where possible to put Covid-19 complications as reason for death, even though the patient may have been asymptomatic and also not even tested for covid. I feel this simply amounts to fraudulently completed death certificates and has been responsible to grossly inflating the number of Covid deaths.
The fact is that regardless of what you actually die of in hospital, it is likely that Covid-19 will feature on your death certificate. I have included with my statement the detailed published guidance from Government on Death Certification which shows how Covid-19, as a factor is encouraged to at least feature on a death certificate.
Remember Covid-19 itself can not kill. What kills is complications from the virus, typically pneumonia like symptoms. These complications are in reality incredibly rare but have featured and a large amount of death certificates issued in recent months. As long as Covid-19 appears on a death certificate, that death is counted as Covid-19 in the figures released by the ONS and PHE.
I genuinely believe that many death certificates, especially amongst the older 65+ demographic have been fraudulently completed so as to be counted as Covid-19 deaths when in reality Covid-19 complications did not cause the death.
There have been Thursday nights when I stood, alone in my office and cried as I heard people cheering and clapping outside. It sickens me to see all the ‘Thank You NHS’ signs up everywhere and the stolen rainbow that for me now says one word and word only; fear.
There are many good people in the NHS and whilst I do not plead forgiveness for myself, I do plead for them. Most are on low pay, they joined for the right reasons and I did and have been bullied and threatened that if they don’t ‘stay on message’ they don’t eat. I know that if a way could be found to assure staff within the NHS of safety against reprisals, there would be a tsunami of whistleblowers which I have no doubt would help end this complete and brutal insanity.
I am finding it increasingly hard to live with what I have been involved in and I am sorry this has happened.
To end, I would simply say this.
Politicians haven’t changed, the country has just made a fatal mistake and started trusting them without question.
Government
Delivering a Real-time Genomics OS to Healthcare
When the opportunity arose to work with population genomics company Helix on a large genomic screening program, Judge was incredibly enthusiastic. With…
Share this:
Director of the Cardiovascular Genetics Program and Fellowship Director for Cardiovascular Disease
The Medical University of South Carolina (MUSC)
When Daniel Judge, MD, director of the Cardiovascular Genetics program and fellowship director for cardiovascular disease at The Medical University of South Carolina (MUSC), moved over from John Hopkins a bit over five years ago, the use of genetics in clinical practice was absent in South Carolina.
“When you ask a clinician what genetics means, it’s often infants with phenylketonuria (PKU) or inherited disorders of metabolism,” Judge told Inside Precision Medicine. “But for adults with cardiovascular, pulmonary, or renal disease, not everyone uses genetics routinely in practice.”
So when the opportunity arose to work with population genomics company Helix on a large genomic screening program, Judge was incredibly enthusiastic.
“Here’s an opportunity for us and MUSC to stand apart from the large for-profit hospital centers that operate around the state, and for us to provide an academic and improved healthcare approach to things,” said Judge. “This was the opportunity for clinicians who have been doing good clinical work to bring genetics into their practice.”
In 2021, MUSC launched “In Our DNA, SC,” a first-of-its-kind genomics program to drive preventive, precision health care for South Carolinians. The statewide initiative has set out to enroll 100,000 patients in genetic testing over the next four years at no cost to the patients.
Walking the walk
Excluding COVID-19, the top cause of death in South Carolina is heart disease, followed by cancer. In the time that In Our DNA SC has been up and running, the cancer and heart disease rates haven’t yet begun to go down, but that’s the goal. Judge estimates that the program has detected about 175 positive results, which are split across breast cancer, colon cancer, and hyperlipidemia.
“Many of those patients with those results were quite surprised because they don’t have a family history of cancer or heart disease,” said Judge. “It’s nice to diagnose it because we’re seeing the ability to prescribe medications on the clinical side that are available more readily for people with familial hyperlipidemia or hypercholesterolemia.”
Judge is excited about the opportunity to provide an academic and improved healthcare approach. “It’s an opportunity for clinicians who have been doing great clinical work but haven’t integrated genetics into their primary care, or whatever that practice might be,” he said. “I think the use of genetics in clinical practice…is entering that mainstream. The patient benefits, and the family benefits.”
Judge’s experience in clinical genetics started about twenty years ago, and “I’ve always seen this pattern: once people see a successful use of something like this, they want to do more of it,” he said. “I think our clinicians will witness success with their patients and will want to see more.”
Making genomics part of real-time care
Founder, Helix
Behind the scenes of the In Our DNA SC initiative is a population genomics company called Helix that strives to accelerate the integration of genomic data into patient care and public health decision-making. Founder James Lu, MD, PhD, has dreamt of a world where genetic testing will provide a real-time response versus one that takes weeks. He set his sights on offering top-tier provider and patient experiences by making genomics a part of the healthcare fabric.
Lu thinks the best way to deliver genomics as a data stream or operating system within healthcare is to work with health systems. “Most of our partnerships are with large-scale health systems and are focused on large-scale, population-level programs,” said Lu. “Typically, a hundred thousand people plus, where they inevitably believe that this is going to become the standard of care over time.”
Lu believes that health systems will want to do this because it allows them to identify patients who are clearly at risk and are hiding in plain sight, such as carriers of well-established deleterious DNA variants. Helix went the route of whole exome sequencing (WES) rather than looking at an entire genome, as Lu believes that the coding regions contain almost all the relevant genomic data for clinical decision-making.
With its genomics data, Helix is currently narrowly focused on the diseases that are part of the CDC Tier 1 genomic application toolkit. This set addresses the nearly two million people in the United States who are at increased risk for adverse health outcomes because they have genetic mutations that predispose them to one of three conditions: hereditary breast and ovarian cancer syndrome (HBOC), Lynch syndrome (LS), or familial hypercholesterolemia (FH). The healthcare system currently has a poor understanding of these conditions, and many affected people and their families are unaware that they are at risk; however, early detection and intervention could significantly lower morbidity and mortality.
The type of work that Helix is doing enables health systems to create fresh population health and value-based care algorithms to manage the health of larger populations. Over time, health systems want to drive the cost of care down while improving the quality of patient experiences.
From sea to shining sea
In addition to In Our DNA, SC, Helix currently has five other major programs running across the country that represent over 100,000 people in total, representing potentially one of the largest-scale programs across America’s health systems.
VP of primary care, clinic operations, and laboratories HealthPartners
In addition to South Carolina, Helix is located in Minnesota, where it is working with HealthPartners on a program called “myGenetics.” This large-scale community health research program, which launched in May 2022, is a first of its kind in Minnesota. Implementing this requires knowing what information to analyze, interpret, and communicate to patients, which Leslie Dockan, VP of primary care, clinic operations, and laboratories at HealthPartners, said aligns nicely with its and Helix’s core principle of providing clinicians with clear decision support.
The myGenetics program is free to the patient, given that it is a research project and the goal is to further biomedical understanding. “We wanted to create workflows that were easy for patients and weren’t disruptive to patient visits in the clinic, because our primary care clinicians have so many responsibilities and so many things that are happening,” said Dockan. This required HealthPartners to work closely with its electronic medical group and Helix to create a seamless workflow.
A day in the myGenetics life
After signing up and consenting electronically, the patient gets an automatic email to schedule their lab appointment at a pace that suits them. “They can take their time, ask questions, and review the information at a time when they’re comfortable, not feeling pressured to move into this,” said Dockan.
Once the appointment is scheduled, the patient gives a blood sample and receives clear information on what to expect, including how long sample processing takes and the information researchers will be looking for. From the results, HealthPartners shares information with the patient about the genes that it has screened for and what the results mean, in addition to facts about the patient’s ancestry and other genetic insights.
While this is happening, the clinical results for the CDC Tier 1 Genomic Applications Toolkit gets fed into the patient’s clinical record for any positive results. In the case of such a result, a nurse calls the patient and notifies them of the result, and offers a no obligation appointment with a genetic counselor to talk about their risk, what their results mean, and any additional testing that might be needed. Direct referrals get set up with a specialist. “If you need an oncology, cardiac, or a gastroenterology referral, we do that work for them, put the referral in, order any follow-up labs that may be needed, and set them on a clear clinical pathway,” said Dockan.
This information also goes to the primary care physician as part of the patient’s medical record, which impacts their future health maintenance, namely, how often screening occurs. “If they have a genetic variant, it doesn’t necessarily mean that they have the disease or will get the disease,” said Dockan. “So, we follow them closely and then have that as a part of their ongoing health maintenance and preventative care.”
Dockan said that genomics will be brought into everyday care, such as with pharmacogenomics. “Physicians will be able to see that there are drug-gene interactions,” said Dockan. “If your physician starts to order a drug that’s not going to be compatible with your genetic makeup and how you metabolize drugs, then we want to be able to alert your clinician at the time of order and have them be able to give you an alternative. Today, we have many people on drugs that just don’t work for them, and no one knows why.”
Outreach in every corner
As of June 2023, myGenetics has had 25,000 people consent, which is about the annual number its organizers are shooting for. “We’re starting to see positive results and have more people who are benefiting from this work in a positive way and learning things about themselves,” said Dockan. “We just identified our first early cancer—someone who was underage and not yet even at screening age came back positive for BRCA2. We ended up doing follow-up screening and an MRI, and we found cancer. She’s crediting the program with potentially saving her life.”
Dockan would like to see the next step of the program’s outreach be to everyone who’s due for their annual physical or a preventative exam. “We want to offer it with all of our mammography screenings,” said Dockan. “We have amazing screening rates for mammography, and this is just another layer that takes it even further.”
Dockan also wants to make sure that myGenetics is reaching underserved communities. She tells a story about a black woman in her fifties who has a long history of breast cancer in her family and found out that she was positive for one of the gene variants that put her at higher risk. Dockan thinks that this story can have a major influence on the communities of black women in Minnesota. Not only is there a benefit in getting the word out so that people get better immediate treatment, but the myGenetics team knows that patients of color are underrepresented in a lot of research databases and wants to help fuel new therapies and other ways of fighting disease in local underserved populations.
Judge laments that the program wasn’t in place several years earlier so that it could have worked in time for a famous South Carolina resident, Chadwick Bozeman. The actor developed metastatic colon cancer in his late thirties, well before colon cancer screening was done. Part of the plan for In Our DNA SC is to become one of the top-enrolled genomic screening programs for non-white participants. “We are in the southeast U.S., and while we are in the 15–16% range, we want to be like 30% of our participants who are non-white, predominantly black, representing our state,” said Judge. “When we look at what our goal is for inclusion in this program, we want the demographics in our publications to look like the state of South Carolina. We’re not there yet.”
Jonathan D. Grinstein’s wonder for the human mind and body led him to an undergraduate education in Neural Science and Philosophy and a doctorate in Biomedical science. He has 10 years of experience in experimental and computational research, during which he was a co-author on research articles in journals such as Nature and Cell. Since then, Jonathan hung up his lab coat and has explored positions in science writing and editing. Jonathan’s science writing work has been featured in Scientific American, Genetic Engineering and Biotechnology News (GEN), and NEO.LIFE.
The post Delivering a Real-time Genomics OS to Healthcare appeared first on Inside Precision Medicine.
fed cdc treatment testing genetic dna mortality covid-19Spread & Containment
As Mortgage Rates Hit 8%, US Housing Affordability At Lowest Level Since The ’80s
As Mortgage Rates Hit 8%, US Housing Affordability At Lowest Level Since The ’80s
Update (1320ET): The average rate on the popular 30-year…
Share this:
Update (1320ET): The average rate on the popular 30-year fixed mortgage rate hit 8% Wednesday morning, according to Mortgage News Daily.
That is the highest level since mid-2000.
“Here’s another milestone that seemed extreme several short months ago,” said Matthew Graham, chief operating officer of Mortgage News Daily.
“The fact is that many borrowers have already seen rates over 8%. That said, many borrowers are still seeing rates in the 7s due to buydowns and discount points.”
As CNBC reports, to put it in perspective, a buyer purchasing a $400,000 home with a 20% down payment would have a monthly payment today of nearly $1,000 more than it would have been two years ago.
* * *
As Andrew Moran detailed earlier via The Epoch Times, the U.S. housing market has witnessed a slowdown in activity this year due to tighter supply, says Thomas Barkin, the president of the Federal Reserve Bank of Richmond.
Speaking at a Real Estate Roundtable event in Washington, D.C., Mr. Barkin explained that home prices have remained strong in an environment of higher interest rates and slowing sales volumes.
But the industry has been pining for lower rates, he noted.
"You may know that the last time the Fed tackled high inflation, in the ’80s, homebuilders sent Paul Volcker two-by-fours inscribed with the message: Lower interest rates," he said.
In a letter to Fed Chair Jerome Powell by the National Association of Home Builders, the Mortgage Bankers Association, and the National Association of Realtors, the central bank was urged not to pull the trigger on more rate hikes.
"Further rate increases and a persistently wide spread pose broader risks to economic growth, heightening the likelihood and magnitude of a recession," the letter stated.
A treasure trove of data and research shows that further Fed tightening could exacerbate current conditions in the real estate sector, especially regarding affordability.
Housing Affordability Challenges
With supply failing to keep up with demand and mortgage rates marching toward 8 percent, housing affordability deteriorated to a fresh all-time low in August, new industry data show.
The NAR Housing Affordability Index clocked in at 91.7 in August, down from 93.9 in July - anything below 100 indicates a household with a median income does not earn enough to be approved for a mortgage on a median-priced home. This was the lowest reading since at least the early 1980s.
NAR figures highlighted that the typical family needed to earn $107,232 in August to qualify for a mortgage, based on a 20 percent downpayment. It was the third consecutive month of a six-figure headline number.
Meanwhile, the organization reported that the average family spent more than one-quarter (27 percent) of their income on annual mortgage payments.
Housing inventories have worsened over the past year. Existing home sales have declined in 13 of the last 15 months, including a 0.7 percent drop in August.
The challenge faced by the U.S. real estate market today is that homeowners are not erecting for-sale signs on their front lawns.
When the Federal Reserve slashed interest rates to nearly zero during the coronavirus pandemic, mortgage rates crashed to their lowest levels on record.
According to the Freddie Mac Primary Mortgage Market Survey (PMMS), the 30-year fixed-rate mortgage collapsed to 2.77 percent in August 2021. For the week ending Oct. 12, 2023, it is close to a 23-year high of 7.6 percent.
Home prices have also surged since the public health crisis, rising nearly 30 percent to a median sales price of $416,100.
The mix of high mortgages and prices has prevented the new generation of homebuyers from achieving the American dream of homeownership. However, anyone who purchased a home before the U.S. central bank launched its quantitative tightening cycle is in good shape: a 2 to 4 percent 30-year mortgage rate and a residential property that has accumulated plenty of equity.
This past summer, a Redfin analysis revealed that 92 percent of homeowners enjoyed a mortgage rate below 6 percent, offering minimal incentive for owners to sell their properties and move to another home with a higher rate. Nearly one-quarter (24 percent) maintain a rate below 3 percent, close to a record high achieved in the first quarter of 2022.
Ultimately, it could be a tale of two housing market participants.
Andy Walden, the ICE vice president of enterprise research, warned that incomes would have to spike 55 percent or home prices would have to collapse 35 percent to restore affordability.
"Those are massive movements we're talking about, and none of them are going to happen in a vacuum, and none of those one single factors are going to make the move," Mr. Walden told CNBC earlier this month.
Mortgage Rates Now and Beyond
The National Association of Home Builders (NAHB)/Wells Fargo Housing Market Index (HMI) found that builder confidence in the real estate market for newly constructed single-family homes slumped for the third consecutive month in October. They are seeing lower levels of buyer traffic as some buyers, including the younger families, are "priced out of the market because of higher interest rates," says NAHB Chairman Alicia Huey, a custom home builder and developer.
"Higher rates are also increasing the cost and availability of builder development and construction loans, which harms supply and contributes to lower housing affordability," Ms. Huey added.
A construction worker carries materials as he works on a home under construction at a housing development in Petaluma, Calif., on March 23, 2022. (Justin Sullivan/Getty Images)
NAHB Chief Economist Robert Dietz noted that one of the primary tools available to solve the housing affordability crisis is contributing "attainable, affordably supply."
"Boosting housing production would help reduce the shelter inflation component that was responsible for more than half of the overall Consumer Price Index increase in September and aid the Fed’s mission to bring inflation back down to 2%," he said. "However, uncertainty regarding monetary policy is contributing to affordability challenges in the market.”
The September consumer price index (CPI) shelter index is up 7.2 percent compared to a year ago.
While the futures market is pricing in the Fed, keeping rates unchanged at the November and December Federal Open Market Committee (FOMC) policy meetings, the central bank’s Summary of Economic Projections suggests officials are planning one more rate hike this year.
In addition, Treasury yields have been accelerating, with the 2-, 10-, and 30-year yields touching their highest levels in 16 years. The volatility in the bond market has played a critical role in the housing market because mortgage lenders tie their interest rates closely to Treasury bond rates.
As a result, Fannie Mae projects that mortgage rates will hover in the 7 percent range for most of next year before sliding to 6.7 percent by the end of 2024.
"In many ways, the housing market experienced four years of business in a two-year period between mid-2020 and mid-2022," said Doug Duncan, Fannie Mae Senior Vice President and Chief Economist.
"With ongoing affordability constraints and rising mortgage rates, much of that activity has essentially been given back. We expect the higher mortgage rate environment to continue to dampen housing activity and further complicate housing affordability into 2024."
The FOMC will hold its next two-day policy meeting on Oct. 31 and Nov. 1.
Spread & Containment
Backlash forces Goldman Sachs CEO to give up side gig he absolutely loves
It was the day the music died at Goldman Sachs as the CEO reportedly packs in his side hustle.
Share this:
Hey, Mr D.J.--get back to work!
Everyone knows that party can't get started until the DJ shows up.
Weddings, private parties, holiday bashes, you need somebody to spin records, get people dancing and to make sure that nobody's car is blocking the driveway.
Related: Elon Musk takes a shot at Tesla's most prominent U.S. electric vehicle rival
Just think of some the legendary DJs, such as Grandmaster Flash, Frankie Knuckles, David Guetta, and, of course, DJ D-Sol.
Craig Barritt/Getty Images for Casamigos
Wait, what? Who was that last guy?
Proceeds go to charities
DJ D-Sol is the nom de disc of David Solomon, whose day job is chairman and CEO of Goldman Sachs (GS) - Get Free Report.
Solomon, 61, has performed a variety of high-profile gigs in recent years, including a performance last summer at the Lollapalooza music festival in Chicago.
However, the top executive has changed his tune and pulled the plug on his musical side hustle, according to the Financial Times.
His hobby reportedly hit a sour note in some circles within the company, who felt that his DJ schtick created a distraction from his work leading the Wall Street firm, the publication reported, citing people with knowledge of the decision.
Some folks were uneasy about his decision in 2019 to perform at Tomorrowland, a Belgian music festival known for heavy drug taking.
Solomon, who was named chief executive in 2018, also apologized to Goldman’s board in 2020 after he DJed at a 2020 event in the Hamptons resort area of New York that was criticized for blowing off social distancing rules during the Covid-19 pandemic.
His interest in DJing started more than a decade ago when he was working on a financing deal for a Las Vegas casino. He has said that proceeds from his performance have gone towards charities combating addiction.
'Music not a distraction'
Few colleagues remarked on his hobby before he became CEO, but his decision to keep it up after taking over the top spot was controversial for some employees who felt it brought unwelcome attention.
Amid all this, Solomon has been under fire from some investors over the bank's lackluster profits.
In the second quarter, Goldman posted its lowest quarterly profit in three years, as a costly retreat from consumer banking was compounded by the industry-wide slowdown in deals and trading
The investment bank posted better-than-expected third quarter earnings on Oct. 17, but booked more than $800 million in write downs linked to its real estate and home improvement lending divisions.
Goldman Sachs maintains that any controversy about Solomon's deejaying is just so much chin music.
"This is not news," spokesman Tony Fratto told the Financial Times. "David hasn’t publicly DJed an event in well over a year, which we have confirmed multiple times in the past."
"Music was not a distraction from David’s work," Fratto added. "The media attention became a distraction."
- Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
EUR/AUD potential short-term downside pressure after upbeat China data
Tesla rival Stellantis unveils its lowest price electric vehicles
As Mortgage Rates Hit 8%, US Housing Affordability At Lowest Level Since The ’80s
Backlash forces Goldman Sachs CEO to give up side gig he absolutely loves
Star Alliance opens new lounge at Paris CDG Airport “carefully curated for a multi-sensorial experience”
Euro slips as Eurozone inflation falls to 4.3%
Compatible seabirds may make better parents, but personality clashes can lead to family tragedy and ‘divorce’
Amish culture prizes peace − but you wouldn’t necessarily know it from a stop in Amish Country tourist towns
COVID-19 vaccine mandates have come and mostly gone in the US – an ethicist explains why their messy rollout matters for trust in public health
New insights into the genetics of the common octopus: genome at the chromosome level decoded
-
Uncategorized19 hours agoOpenAI partners with G42 in Dubai eyeing Middle East expansion
-
International16 hours ago
Tesla rival Stellantis unveils its lowest price electric vehicles
-
Spread & Containment23 hours ago
As Mortgage Rates Hit 8%, US Housing Affordability At Lowest Level Since The ’80s
-
Uncategorized18 hours agoThe GDP Outlook: Now and Near Future
-
Uncategorized21 hours agoUMass Amherst engineering professor is awarded $1.9 million to push the bounds of cancer, heart disease research
-
International18 hours agoUS Troops In Iraq Under Fresh Drone Attacks After Iran Said “Time Is Up”
-
International21 hours agoGenerative AI and Precision Medicine—The Future Is Not What It Used to Be
-
International21 hours agoJimmy Buffett’s cruise line makes a surprise expansion move